Synopsis This study investigates the impact of excessive glutathione intake on breast cancer chemotherapy resistance, showing that higher intake is linked to increased recurrence rates and poor prognosis, emphasizing the need for standardized glutathione usage during treatment
As a result, these tumors tend to be larger and less amenable to curative therapies than those with other etiologies7
Prostate, pancreatic, and kidney cancers showed no statistically significant difference
Barros LF, Schirmeier S, Weber B
Mechanism of action, non-selective activation of the melanocortin system Melanotan II activates all four functional melanocortin receptors (MC1R, MC3R, MC4R, MC5R) with high affinity
The dose escalation schedules differ between the two medications: Semaglutide Dose Escalation Weeks 14: 0.25mg weekly (initiation dose) Weeks 58: 0.5mg weekly Weeks 912: 1.0mg weekly Weeks 1316: 1.7mg weekly Week 17+: 2.4mg weekly (maintenance dose for weight loss) Tirzepatide Dose Escalation Weeks 14: 2.5mg weekly (initiation dose) Weeks 58: 5mg weekly Weeks 912: 7.5mg weekly (many patients maintain here) Weeks 1316: 10mg weekly Weeks 1720: 12.5mg weekly Week 21+: 15mg weekly (maximum dose) Not every patient needs to reach the maximum dose and at BlueWater Wellness Center, we don't escalate for the sake of it
